XML 17 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments
12 Months Ended
Mar. 30, 2012
Financial Instruments [Abstract]  
Financial Instruments
Note 2.  Financial Instruments
 
Short-term investments at March 30, 2012 and March 25, 2011 consisted of the following:
 
(in thousands)
 
Amortized
Cost
  
Gross
Unrealized
Gains
  
Gross
Unrealized
Losses
  
Estimated
Market
Value
 
March 30, 2012
            
U.S. Treasury notes
 $3,953  $2  $(3) $3,952 
U.S. government agencies
  7,465   10   -   7,475 
Corporate notes and bonds
  10,757   24   (3)  10,778 
Asset backed securities
  3,530   9   (2)  3,537 
Other debt securities
  503   -   -   503 
   $26,208  $45  $(8) $26,245 
March 25, 2011
                
U.S. Treasury notes
 $3,222  $10  $(1) $3,231 
U.S. government agencies
  17,297   34   (15)  17,316 
Corporate notes and bonds
  20,507   66   (13)  20,560 
Asset backed securities
  14,187   61   (21)  14,227 
Other debt securities
  1,523   4   (1)  1,526 
  $56,736  $175  $(51) $56,860 
 
The maturities of short-term investments at March 30, 2012 are as follows:

(in thousands)
 
Amortized
Cost
  
Estimated
Market Value
 
Maturing in one year
 
$
8,625
  
$
8,637
 
Maturing in one to five years
  
17,583
   
17,608
 
Total
 
$
26,208
  
$
26,245
 

Unrealized gain positions for short-term investments held twelve months or more were $21,000 and $187,000 at March 30, 2012 and March 25, 2011, respectively.

The following table summarizes the financial assets and liabilities of the Company measured at fair value on a recurring basis:

(in thousands)
    
Fair Value Measurements at
 March 30, 2012, Using
 
  
Balance as of
March
 30, 2012
  
Level 1
  
Level 2
 
Assets:
         
U.S. Treasury notes(1)
 
$
3,952
  
$
3,952
  
$
-
 
U.S. government agencies(1)
   
7,475
     
-
     
7,475
 
Corporate notes and bonds(1)
   
10,778
     
-
     
10,778
 
Asset backed securities(1)
   
3,537
     
-
     
3,537
 
Other debt securities(1)
  
503
   
-
   
503
 
Total
 
$
26,245
  
$
3,952
  
$
22,293
 
 
(in thousands)
    
Fair Value Measurements at
 March 25, 2011, using
 
  
Balance as of
March
 25, 2011
  
Level 1
  
Level 2
 
Assets:
         
U.S. Treasury notes(1)
 
$
3,231
  
$
3,231
  
$
-
 
U.S. government agencies(1)
  
17,316
   
-
   
17,316
 
Corporate notes and bonds(1)
   
20,560
     
-
     
20,560
 
Asset backed securities(1)
   
14,227
     
-
     
14,227
 
Other debt securities(1)
  
1,526
   
-
   
1,526
 
     
56,860
     
3,231
     
53,629
 
Foreign currency derivatives(2)
   
31
     
-
     
31
 
Total
 
$
56,891
  
$
3,231
  
$
53,660
 
                
Liabilities:
              
Foreign currency derivatives(3)
 
$
112
  
$
-
  
$
112
 
Total
 
$
112
  
$
-
  
$
112
 
 
(1)
Included in short-term investments on the Company's consolidated balance sheet.
(2)
Included in accounts receivable on the Company's consolidated balance sheet.
(3)
Included in accrued liabilities on the Company's consolidated balance sheet.

The three levels of the fair value hierarchy are:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Observable inputs other than quoted prices included within Level 1, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs other than quoted prices that are observable or are derived principally from, or corroborated by, observable market data by correlation or other means.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
 
The valuation techniques used to measure the fair value of financial instruments, all of which have counterparties with high credit ratings, were valued based on quoted market prices or model driven valuations using significant inputs derived from or corroborated by observable market data.
 
Investments are classified within Level 1 if quoted prices are available in active markets.
 
Items are classified in Level 2 if the investments are valued using quoted prices for identical assets in markets that are not active, using quoted prices for similar assets in an active market, or using model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets.
 
The Company did not hold financial assets or liabilities which were recorded at fair value using inputs in the Level 3 category as of March 30, 2012 and March 25, 2011.
 
Derivative financial instruments are limited to foreign exchange contracts which the Company enters into to minimize certain balance sheet exposures and intercompany balances against future movement in foreign exchange rates. The Company's primary net foreign currency exposures are in Japanese yen, Euros, and British pounds. The fair value of the Company's derivative instruments is determined using pricing models based on current market rates. Gains and losses on these foreign exchange contracts, which are not designated as hedging instruments, are included in other income and expense, net, and were not material for any period presented. As of March 30, 2012, the Company had no outstanding foreign exchange contracts.